Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pharmacogenetics of tardive dyskinesia: an updated review of the literature.

Pharmacogenomics - 1 Aug 2016

Lanning Rachel K, Zai Clement C, Müller Daniel J

Abstract excerpt

Tardive dyskinesia (TD) is a serious and potentially irreversible side effect of long-term exposure to antipsychotic medication characterized by involuntary trunk, limb and orofacial muscle movements. Various mechanisms have been proposed for the etiopathophysiology of antipsychotic-induced TD in schizophrenia patients with genetic factors playing a prominent role. Earlier association studies have focused on...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Schizophrenia
Share to Antipsychotic Agents
Share to CNR1 gene

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Predisposition to Disease

Share to Genomics and Rare Diseases

Share to Lysosomal Storage Disorders Research

Share to Pharmacogenetics

Share to Schizophrenia research and treatment

Source

Identifiers

PMID: 27469238
DOI: 10.2217/pgs.16.26

Genes

CNR1
DPP6
HSPG2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pharmacogenetics of tardive dyskinesia: an updated review of the literature.PMID 27469238Read ↗

Genetic underpinnings of tardive dyskinesia: passing the baton to pharmacogenetics.Semantic proximity Read ↗

Genetic Factors Associated With Tardive Dyskinesia: From Pre-clinical Models to Clinical StudiesSemantic proximity Read ↗

Genetics of tardive dyskinesia: a review of progress over the past decade.Semantic proximity Read ↗

New findings in pharmacogenetics of schizophreniaSemantic proximity Read ↗

Genetics of tardive dyskinesia.Semantic proximity Read ↗

Genetics of Common Antipsychotic-Induced Adverse EffectsSemantic proximity Read ↗

Pharmacogenetics-Guided Advances in Antipsychotic Treatment.Semantic proximity Read ↗

Pharmacogenetic assessment of antipsychotic-induced movement disorders: contribution of the dopamine D3 receptor and cytochrome P450 1A2 genes.Semantic proximity Read ↗

Association study of tardive dyskinesia and five DRD4 polymorphisms in schizophrenia patientsSemantic proximity Read ↗

Epidemiology and risk factors for (tardive) dyskinesia.Semantic proximity Read ↗

Pharmacogenetics of antipsychotic-induced side effects.Semantic proximity Read ↗

Analysis of genetic variations in the dopamine D1 receptor (DRD1) gene and antipsychotics-induced tardive dyskinesia in schizophrenia.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.